These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29530466)

  • 1. Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.
    Azevedo R; Soares J; Peixoto A; Cotton S; Lima L; Santos LL; Ferreira JA
    Urol Oncol; 2018 May; 36(5):221-236. PubMed ID: 29530466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technologies for circulating tumor cell separation from whole blood.
    Bankó P; Lee SY; Nagygyörgy V; Zrínyi M; Chae CH; Cho DH; Telekes A
    J Hematol Oncol; 2019 May; 12(1):48. PubMed ID: 31088479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells: Overview and Opportunities in Cytology.
    Sundling KE; Lowe AC
    Adv Anat Pathol; 2019 Jan; 26(1):56-63. PubMed ID: 30325755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis.
    Tadimety A; Syed A; Nie Y; Long CR; Kready KM; Zhang JX
    Integr Biol (Camb); 2017 Jan; 9(1):22-49. PubMed ID: 27929582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
    Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
    Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review.
    Khetrapal P; Lee MWL; Tan WS; Dong L; de Winter P; Feber A; Kelly JD
    Cancer Treat Rev; 2018 May; 66():56-63. PubMed ID: 29684744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cell clusters: What we know and what we expect (Review).
    Hong Y; Fang F; Zhang Q
    Int J Oncol; 2016 Dec; 49(6):2206-2216. PubMed ID: 27779656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Quantitation of Circulating Tumor Cells.
    Rawal S; Yang YP; Cote R; Agarwal A
    Annu Rev Anal Chem (Palo Alto Calif); 2017 Jun; 10(1):321-343. PubMed ID: 28301753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and Challenges for Pancreatic Circulating Tumor Cells.
    Nagrath S; Jack RM; Sahai V; Simeone DM
    Gastroenterology; 2016 Sep; 151(3):412-26. PubMed ID: 27339829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
    Rossi G; Ignatiadis M
    Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.
    Rink M; Schwarzenbach H; Riethdorf S; Soave A
    World J Urol; 2019 Sep; 37(9):1785-1799. PubMed ID: 30367205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis.
    Msaouel P; Koutsilieris M
    BMC Cancer; 2011 Aug; 11():336. PubMed ID: 21816094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.
    Tong B; Wang M
    Future Oncol; 2019 Jul; 15(21):2531-2542. PubMed ID: 31339062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
    Chen S; El-Heliebi A; Kroneis T
    Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
    Yap K; Cohen EN; Reuben JM; Khoury JD
    Curr Hematol Malig Rep; 2019 Oct; 14(5):353-357. PubMed ID: 31364034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes.
    Nagata M; Muto S; Horie S
    Dis Markers; 2016; 2016():8205836. PubMed ID: 26924873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor Cells: Applications in Cytopathology.
    Lowe AC
    Surg Pathol Clin; 2018 Sep; 11(3):679-686. PubMed ID: 30190148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.